Skip to content

Title 22 — Foreign Relations and Intercourse

Part VIII · Chapter 32 — Foreign Assistance

§ 2291l. Prioritization of efforts of the Department of State to combat international trafficking in covered synthetic drugs

Statutory text

(a)

In general

The Secretary of State shall prioritize efforts of the Department of State to combat international trafficking of covered synthetic drugs by carrying out programs and activities to include the following:

(1)

Supporting increased data collection by the United States and foreign countries through increased drug use surveys among populations, increased use of wastewater testing where appropriate, and multilateral sharing of that data.

(2)

Engaging in increased consultation and partnership with international drug agencies, including the European Monitoring Centre for Drugs and Drug Addiction, regulatory agencies in foreign countries, and the United Nations Office on Drugs and Crime.

(3)

Carrying out programs to provide technical assistance and equipment, as appropriate, to strengthen the capacity of foreign law enforcement agencies with respect to covered synthetic drugs, as required by section 2291m of this title.

(4)

Carrying out exchange programs for governmental and nongovernmental personnel in the United States and in foreign countries to provide educational and professional development on demand reduction matters relating to the illicit use of covered synthetic drugs and other drugs, as required by section 2291n of this title.

(b)

Report

(1)

In general

Not later than one year after , the Secretary of State shall submit to the appropriate congressional committees a report on the implementation of this section.

(2)

Appropriate congressional committees defined

In this subsection, the term “appropriate congressional committees” means—

(A)

the Committee on Foreign Relations, the Committee on Appropriations, and the Committee on the Judiciary of the Senate; and

(B)

the Committee on Foreign Affairs, the Committee on Appropriations, and the Committee on the Judiciary of the House of Representatives.

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

  1. Fighting Emerging Narcotics Through Additional Nations to Yield Lasting Results Act

    Pub. L. 117–263 div. E title LV § 5552 · 136 Stat. 2395

    Enacted · 22 U.S.C. § 2291l

    (Pub. L. 117–263, div. E, title LV, § 5552, Dec. 23, 2022, 136 Stat. 3341.)

    Source evidence

    Code source credit
    (Pub. L. 117–263, div. E, title LV, § 5552, Dec. 23, 2022, 136 Stat. 3341.)

    Enacted provision · exact public law section
    SEC. 5552. PRIORITIZATION OF EFFORTS OF THE DEPARTMENT OF STATE TO COMBAT INTERNATIONAL TRAFFICKING IN COVERED SYNTHETIC DRUGS. (a) In General.— The Secretary of State shall prioritize efforts of the Department of State to combat international trafficking of covered synthetic drugs by carrying out programs and activities to include the following: (1) Supporting increased data collection by the United States and foreign countries through increased drug use surveys among populations, increased use of wastewater testing where appropriate, and multilateral sharing of that data. (2) Engaging in increased consultation and partnership with international drug agencies, including the European Monitoring Centre for Drugs and Drug Addiction, regulatory agencies in foreign countries, and the United Nations Office on Drugs and Crime. (3) Carrying out programs to provide technical assistance and equipment, as appropriate, to strengthen the capacity of foreign law enforcement agencies with respect to covered synthetic drugs, as required by section 5553. (4) Carrying out exchange programs for governmental and nongovernmental personnel in the United States and in foreign countries to provide educational and professional development on demand reduction matters relating to the illicit use of covered synthetic drugs and other drugs, as required by section 5554. (b) Report.— (1) In general.— Not later than one year after the date of the enactment of this Act, the Secretary of State shall submit to the appropriate congressional committees a report on the implementation of this section. (2) Appropriate congressional committees defined.— In this subsection, the term “appropriate congressional committees” means— (A) the Committee on Foreign Relations, the Committee on Appropriations, and the Committee on the Judiciary of the Senate; and (B) the Committee on Foreign Affairs, the Committee on Appropriations, and the Committee on the Judiciary of the House of Representatives.

1 of 1 references resolved to an enrolled provision

Editorial Notes

Codification

Section was enacted as part of the Fighting Emerging Narcotics Through Additional Nations to Yield Lasting Results Act, also known as the FENTANYL Results Act, and also as part of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, and not as part of the Foreign Assistance Act of 1961 which comprises this chapter.

Statutory Notes and Related Subsidiaries

Rule of Construction

Pub. L. 117–263, div. E, title LV, § 5557, , 136 Stat. 3344, provided that: “Nothing in this subtitle [subtitle C (§§ 5551–5558) of title LV of div. E of Pub. L. 117–263, see Short Title of 2022 Amendment note set out under section 2151 of this title] or the amendments made by this subtitle shall be construed to affect the prioritization of extradition requests.”

Definitions

Pub. L. 117–263, div. E, title LV, § 5558, , 136 Stat. 3344, provided that:

“In this subtitle [subtitle C (§§ 5551–5558) of title LV of div. E of Pub. L. 117–263, see Short Title of 2022 Amendment note set out under section 2151 of this title]:

“(1)

Controlled substance; controlled substance analogue.—

The terms ‘controlled substance’ and ‘controlled substance analogue’ have the meanings given those terms in section 102 of the Controlled Substances Act (21 U.S.C. 802).

“(2)

Covered synthetic drug.—

The term ‘covered synthetic drug’ means—

“(A)

a synthetic controlled substance or synthetic controlled substance analogue, including fentanyl or a fentanyl analogue; or

“(B)

a new psychoactive substance.

“(3)

New psychoactive substance.—

The term ‘new psychoactive substance’ means a substance of abuse, or any preparation thereof, that—

“(A)

is not—

“(i)

included in any schedule as a controlled substance under the Controlled Substances Act (21 U.S.C. 801 et seq.); or

“(ii)

controlled by the Single Convention on Narcotic Drugs, done at New York , or the Convention on Psychotropic Substances, done at Vienna ;

“(B)

is new or has reemerged on the illicit market; and

“(C)

poses a threat to the public health and safety.”

Credits

(Pub. L. 117–263, div. E, title LV, § 5552, , 136 Stat. 3341.)

Parsed from the official OLRC USLM XML in data/usc_all/usc22.xml · release point 119-108 · OLRC build 2026-09-09

USLM identifier /us/usc/t22/s2291l